Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High molecular weight von Willebrand factor (VWF) multimers are the largest and most functionally active forms of VWF, a multimeric glycoprotein essential for hemostasis. VWF is synthesized as a large precursor protein that undergoes multimerization, resulting in a range of sizes. The high molecular weight forms are particularly important for mediating platelet adhesion and aggregation at sites of vascular injury. These large structures have an α–β–α sandwich fold within their subdomains, and are cleaved by the metalloprotease ADAMTS13. Deficiency or dysfunction leads to bleeding disorders such as von Willebrand disease (VWD), while excessive accumulation due to impaired cleavage can cause microvascular thrombosis.
Enhances platelet adhesion and aggregation under high shear stress by binding to platelet glycoprotein Ib/IX/V and subendothelial collagen. Stabilizes Factor VIII.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High Molecular Weight von Willebrand Factor Multimer (HMW-VWF Multimer).